The selective cyclooxygenase‐2 inhibitor SC‐236 reduces liver fibrosis by mechanisms involving non‐parenchymal cell apoptosis and PPARγ activation-Reference-Cited by-同舟云学术

The selective cyclooxygenase‐2 inhibitor SC‐236 reduces liver fibrosis by mechanisms involving non‐parenchymal cell apoptosis and PPARγ activation

Author:

Planagumà Anna¹,Clària Joan¹,Miquel Rosa²,López‐Parra Marta¹,Titos Esther¹,Masferrer Jaime L.¹,Arroyo Vicente³,Rodé Joan³

Affiliation:

1. DNA UnitHospital ClínicInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)Universitat de Barcelona Barcelona Spain

2. Pathology LaboratoryHospital ClínicInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)Universitat de Barcelona Barcelona Spain

3. Liver UnitHospital ClínicInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)Universitat de Barcelona Barcelona Spain

Funder

Ministerio de Ciencia y Tecnología

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

Reference53 articles.

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献